In addition, it has been demonstrated that the serum levels of angiogenic cytokines, such as VEGF and IL-8, are associated with tumor progression in pancreatic neuroendocrine tumor patients, and they might use as biomarkers for prognosis and therapy [52]. Here, VEGFA is linked to neoplasm.